Chronic Lower Back Pain Market Size, Implications and Patient-Centered Approaches

Introduction

• Research Objective
• Scope of the Study
• Definition and Taxonomy

Research Methodology

• Research Approach
• Data Sources
• Assumptions

Executive Summary

• Synopsis
• Analyst Recommendations

Market Overview 

• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
• Value Chain Analysis
  • Raw Material Sourcing
  • Manufacturing Process
  • Logistics & Transportation
  • Buyer Preferences
• Trends
  • Market Trends
  • Technological Trends
• Porter’s Five Forces Analysis
  • Bargaining Power of Suppliers
  • Bargaining Power of Buyers
  • Threat of Substitute
  • Threat of New Entrants
  • Degree of Competition
• PESTLE Analysis for 5 Leading Countries
  
  • Regulatory Framework for Leading Countries/Regions
  • Supply Demand Analysis
  • Production & Consumption Statistics
  • Export Import Statistics
  • Price Trend Analysis

Global Chronic Lower Back Pain Market Assessment

• Overview
• Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
  • Non-steroidal Anti-inflammatory Drugs
  • Antidepressants
  • Analgesic
  • Opioids
  • Others
• Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
  • Oral
  • Topical
  • Others
• Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
  • Hospital Pharmacies
  • Retail & Online Pharmacies
• Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Region (2021 – 2033)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Chronic Lower Back Pain Market Assessment

• Overview
• North America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
  • Non-steroidal Anti-inflammatory Drugs
  • Antidepressants
  • Analgesic
  • Opioids
  • Others
• North America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
  • Oral
  • Topical
  • Others
• North America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
  • Hospital Pharmacies
  • Retail & Online Pharmacies

Europe Chronic Lower Back Pain Market Assessment

• Overview
• Europe Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
  • Non-steroidal Anti-inflammatory Drugs
  • Antidepressants
  • Analgesic
  • Opioids
  • Others
• Europe Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
  • Oral
  • Topical
  • Others
• Europe Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
  • Hospital Pharmacies
  • Retail & Online Pharmacies

Asia Pacific Chronic Lower Back Pain Market Assessment

• Overview
• Asia Pacific Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
  • Non-steroidal Anti-inflammatory Drugs
  • Antidepressants
  • Analgesic
  • Opioids
  • Others
• Asia Pacific Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
  • Oral
  • Topical
  • Others
• Asia Pacific Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
  • Hospital Pharmacies
  • Retail & Online Pharmacies

Latin America Chronic Lower Back Pain Market Assessment

• Overview
• Latin America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
  • Non-steroidal Anti-inflammatory Drugs
  • Antidepressants
  • Analgesic
  • Opioids
  • Others
• Latin America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
  • Oral
  • Topical
  • Others
• Latin America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
  • Hospital Pharmacies
  • Retail & Online Pharmacies

Middle East & Africa Chronic Lower Back Pain Market Assessment

• Overview
• Middle East & Africa Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
  • Non-steroidal Anti-inflammatory Drugs
  • Antidepressants
  • Analgesic
  • Opioids
  • Others
• Middle East & Africa Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
  • Oral
  • Topical
  • Others
• Middle East & Africa Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
  • Hospital Pharmacies
  • Retail & Online Pharmacies

Company Profiles

• SpineThera Inc. (U.S.)
  • Company Overview
  • Geographic Footprints
  • Financial Performance
  • Product Portfolio
  • SWOT Analysis
  • R&D Efforts
  • Recent Developments & Strategic Collaborations
    • Product Launch/M&A/Technical Collaboration
• Pfizer Inc (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Johnson & Johnson Private Limited (U.S.)
• Medtronic (Ireland)
• Endo Pharmaceuticals Inc. (Ireland)
• Sanofi (France)
• Merck & Co Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Vertebral Technologies, Inc. (U.S.)
• Boston Scientific Corporation (U.S.)
• Dr. Reddy’s Laboratories Ltd. (India)
• Astellas Pharma Inc. (Japan)
• CELGENE CORPORATION (U.S.)

Conclusion & Recommendations